Skip to main content
Erschienen in: Clinical Oral Investigations 4/2018

06.12.2017 | Original Article

Sugar-based collagen membrane cross-linking increases barrier capacity of membranes

verfasst von: Po-ju Chia-Lai, Anna Orlowska, Sarah Al-Maawi, Andre Dias, Yunxin Zhang, Xuejiu Wang, Niklas Zender, Robert Sader, C. James Kirkpatrick, Shahram Ghanaati

Erschienen in: Clinical Oral Investigations | Ausgabe 4/2018

Einloggen, um Zugang zu erhalten

Abstract

Objectives

This study examines the permeability and barrier capacity of a sugar cross-linked resorbable collagen membrane ex vivo and in vivo.

Materials and methods

In an ex vivo study, injectable platelet-rich fibrin (i-PRF), a peripheral blood-derived human leukocyte-and-platelet-rich plasma was used to analyze membrane permeability. in vivo subcutaneous implantation in Wistar rats (n = 4 per time point and group) was used to investigate the barrier capacity of the membrane. The induced in vivo cellular reaction was evaluated at 3, 15, and 30 days and compared to sham OP (control) without biomaterial using histological, immunohistochemical, and histomorphometric methods.

Results

Ex vivo, the membrane was impenetrable to leukocytes, platelets, and fibrin from peripheral human blood concentrate (PRF). In vivo, the membrane maintained its structure and remained impervious to cells, connective tissue, and vessels over 30 days. CD-68-positive cell (macrophage) numbers significantly decreased from 3 to 15 days, while from day 15 onwards, the number of multinucleated giant cells (MNGCs) increased significantly. Correspondingly, a rise in implantation bed vascularization from 15 to 30 days was observed. However, no signs of degradation or material breakdown were observed at any time point.

Conclusion

Ex vivo and in vivo results showed material impermeability to cellular infiltration of human and murine cells, which highlights the membrane capacity to serve as a barrier over 30 days. However, whether the induced MNGCs will lead to material degradation or encapsulation over the long term requires further investigation.

Clinical relevance

The data presented are of great clinical interest, as they contribute to the ongoing discussion concerning to what extent an implanted material should be integrated versus serving only as a barrier membrane.
Literatur
4.
Zurück zum Zitat Patino MG, Neiders ME, Andreana S, Noble B, Cohen RE (2002) Collagen as an implantable material in medicine and dentistry. Research 220 Patino MG, Neiders ME, Andreana S, Noble B, Cohen RE (2002) Collagen as an implantable material in medicine and dentistry. Research 220
6.
Zurück zum Zitat Buser D, Dula K, Hirt HP, Schenk RK (1996) Lateral ridge augmentation using autografts and barrier membranes: a clinical study with 40 partially edentulous patients. J Oral Maxillofac Surg 54:420–432 3CrossRefPubMed Buser D, Dula K, Hirt HP, Schenk RK (1996) Lateral ridge augmentation using autografts and barrier membranes: a clinical study with 40 partially edentulous patients. J Oral Maxillofac Surg 54:420–432 3CrossRefPubMed
13.
14.
15.
Zurück zum Zitat Barbeck M, Lorenz J, Holthaus MG, Raetscho N, Kubesch A, Booms P, Sader R, Kirkpatrick CJ, Ghanaati S (2015) Porcine dermis and pericardium-based, non-cross-linked materials induce multinucleated giant cells after their in vivo implantation: a physiological reaction? J. Oral Implantol. 41(6):e267–e281. https://doi.org/10.1563/aaid-joi-D-14-00155 CrossRefPubMed Barbeck M, Lorenz J, Holthaus MG, Raetscho N, Kubesch A, Booms P, Sader R, Kirkpatrick CJ, Ghanaati S (2015) Porcine dermis and pericardium-based, non-cross-linked materials induce multinucleated giant cells after their in vivo implantation: a physiological reaction? J. Oral Implantol. 41(6):e267–e281. https://​doi.​org/​10.​1563/​aaid-joi-D-14-00155 CrossRefPubMed
21.
Zurück zum Zitat OSSIX PLUS—GLYMATRIX™ Technology in Brief, (n.d.) OSSIX PLUS—GLYMATRIX™ Technology in Brief, (n.d.)
22.
Zurück zum Zitat OSSIX ® PLUS Instructions for Use IFU-MKT-OSP-016 ver OSSIX ® PLUS The Resorbable Collagen Membrane Instructions for Use for OSSIX ® PLUS, (2016) OSSIX ® PLUS Instructions for Use IFU-MKT-OSP-016 ver OSSIX ® PLUS The Resorbable Collagen Membrane Instructions for Use for OSSIX ® PLUS, (2016)
24.
Zurück zum Zitat Choukroun J, Ghanaati S (2017) Reduction of relative centrifugation force within injectable platelet-rich-fibrin (PRF) concentrates advances patients’ own inflammatory cells, platelets and growth factors: the first introduction to the low speed centrifugation concept. Eur J Trauma Emerg Surg. https://doi.org/10.1007/s00068-017-0767-9 Choukroun J, Ghanaati S (2017) Reduction of relative centrifugation force within injectable platelet-rich-fibrin (PRF) concentrates advances patients’ own inflammatory cells, platelets and growth factors: the first introduction to the low speed centrifugation concept. Eur J Trauma Emerg Surg. https://​doi.​org/​10.​1007/​s00068-017-0767-9
27.
Zurück zum Zitat Ghanaati S, Orth C, Unger RE, Barbeck M, Webber MJ, Motta A, Migliaresi C, James Kirkpatrick C (2010) Fine-tuning scaffolds for tissue regeneration: effects of formic acid processing on tissue reaction to silk fibroin. J Tissue Eng Regen Med 4:464–472. https://doi.org/10.1002/term.257 PubMed Ghanaati S, Orth C, Unger RE, Barbeck M, Webber MJ, Motta A, Migliaresi C, James Kirkpatrick C (2010) Fine-tuning scaffolds for tissue regeneration: effects of formic acid processing on tissue reaction to silk fibroin. J Tissue Eng Regen Med 4:464–472. https://​doi.​org/​10.​1002/​term.​257 PubMed
29.
Zurück zum Zitat Choukroun J, Ghanaati S (2016) Reduction of relative centrifugation force within injectable PRF—(platelet-rich-fibrin) concentrates advances patients’ own inflammatory cells, platelets and growth factors: first introduction of the low speed centrifugation concept (LSCC), Eur J Trauma Emerg Surg. accepted Choukroun J, Ghanaati S (2016) Reduction of relative centrifugation force within injectable PRF—(platelet-rich-fibrin) concentrates advances patients’ own inflammatory cells, platelets and growth factors: first introduction of the low speed centrifugation concept (LSCC), Eur J Trauma Emerg Surg. accepted
Metadaten
Titel
Sugar-based collagen membrane cross-linking increases barrier capacity of membranes
verfasst von
Po-ju Chia-Lai
Anna Orlowska
Sarah Al-Maawi
Andre Dias
Yunxin Zhang
Xuejiu Wang
Niklas Zender
Robert Sader
C. James Kirkpatrick
Shahram Ghanaati
Publikationsdatum
06.12.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Clinical Oral Investigations / Ausgabe 4/2018
Print ISSN: 1432-6981
Elektronische ISSN: 1436-3771
DOI
https://doi.org/10.1007/s00784-017-2281-1

Weitere Artikel der Ausgabe 4/2018

Clinical Oral Investigations 4/2018 Zur Ausgabe

Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Zahnmedizin und bleiben Sie gut informiert – ganz bequem per eMail.